The real risk isn't in running robust tests; it’s in wasting money or cutting high-performing channels based on misleading ...

October marks Health Literacy Month, a crucial observance dedicated to highlighting the essential role health literacy plays ...

Many of the randomized controlled trials for large vessel vasculitis with significant or nonsignificant outcomes show fragility, and measures do not vary with the risk for bias, drug type, or subtype.

Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab ...

“Well, we don’t have as much evidence as we would like on steroid use during pregnancy,” the obstetrician warned my co-author, Natalia Emanuel, as she wrote a prescription for inhaled corticosteroids ...